Alpine Immune Sciences Inc (ALPN)

65.00 +0.04 (+0.06%) USD  |  NASDAQ  |  May 17, 16:00
65.00 0.00 (0.00%) After-Hours: 16:08
More

Alpine Immune Sciences Cash and Short Term Investments (Quarterly): 305.66M for March 31, 2024

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
March 31, 2024 305.66M
December 31, 2023 327.41M
September 30, 2023 193.45M
June 30, 2023 203.80M
March 31, 2023 194.92M
December 31, 2022 237.64M
September 30, 2022 248.86M
June 30, 2022 167.86M
March 31, 2022 171.87M
December 31, 2021 162.30M
September 30, 2021 180.63M
June 30, 2021 91.06M
March 31, 2021 96.81M
December 31, 2020 105.58M
September 30, 2020 141.08M
June 30, 2020 90.22M
March 31, 2020 35.68M
December 31, 2019 40.52M
September 30, 2019 46.59M
Date Value
June 30, 2019 55.56M
March 31, 2019 63.96M
December 31, 2018 52.30M
September 30, 2018 61.98M
June 30, 2018 69.94M
March 31, 2018 76.65M
December 31, 2017 81.24M
September 30, 2017 87.20M
June 30, 2017 49.50M
March 31, 2017 52.67M
December 31, 2016 61.04M
September 30, 2016 66.19M
June 30, 2016 73.73M
March 31, 2016 80.21M
December 31, 2015 87.25M
September 30, 2015 92.65M
June 30, 2015 100.52M
March 31, 2015 22.86M
December 31, 2014 27.81M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

35.68M
Minimum
Mar 2020
327.41M
Maximum
Dec 2023
154.88M
Average
165.08M
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Vertex Pharmaceuticals Inc 10.17B
Eliem Therapeutics Inc 106.80M
Regeneron Pharmaceuticals Inc 10.52B
Vera Therapeutics Inc 403.66M
Eyenovia Inc 14.85M